Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Maria Sendino
Hitting a Moving Target: Inhibition of the Nuclear Export Receptor XPO1/CRM1 as a Therapeutic Approach in Cancer
Related publications
Nuclear Export of the Yeast Hexokinase 2 Protein Requires the Xpo1 (Crm1)-Dependent Pathway
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Leptomycin B, an Inhibitor of the Nuclear Export Receptor CRM1, Inhibits COX-2 Expression
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Prostanoid Receptor EP2 as a Therapeutic Target
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
XPO1 (Exportin 1 (CRM1 Homolog, Yeast))
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
A Global Survey of CRM1-dependent Nuclear Export Sequences in the Human Deubiquitinase Family
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
EGFR Family Inhibition Identifies P38 MAPK as a Potential Therapeutic Target in Bladder Cancer
Urology
Urology
Clinical Implications of Targeting XPO1-Mediated Nuclear Export in Multiple Myeloma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
A Role for RanBP1 in the Release of CRM1 From the Nuclear Pore Complex in a Terminal Step of Nuclear Export
Journal of Cell Biology
Medicine
Cell Biology
DNA Methylation as a Therapeutic Target in Cancer
Clinical Cancer Research
Cancer Research
Oncology